Patients on tirzepatide also experienced more metabolic benefits, such as greater reductions in weight and HbA1c, compared with dulaglutide.

Among persons at high cardiovascular risk, there is low- to moderate-certainty evidence that reducing or modifying saturated fat intake can reduce mortality and major cardiovascular events over five ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

New treatments, care gaps, and cardiac monitoring were major focuses in cardiovascular news this year. The top cardiovascular ...

New study reveals prediabetes remission can cut heart disease death risk by 58% through targeted lifestyle changes that keep blood sugar levels within a normal range.

Genetic and epidemiological evidence indicates that triglyceride-rich lipoproteins are causal risk factors for atherosclerotic cardiovascular disease (ASCVD). Elevated levels of plasma triglyceride ...

SaveHealth reports on popular statin medications that lower cholesterol and cardiovascular risks, highlighting their benefits ...

Research indicates that adhering to the Portfolio Diet can help lower cholesterol levels and enhance heart health. This plant ...

MÁLAGA, Spain — Semaglutide (Wegovy) is associated with a 41% reduction in the risk for major adverse cardiovascular events (MACEs) within 6 months of initiation — well before patients achieve ...

Researchers from Philadelphia-based University of Pennsylvania’s Leonard Davis Institute of Health Economics recently found that coronary artery bypass grafts are the most lucrative cardiology ...

Depression and anxiety may heighten cardiovascular disease risk through chronic stress pathways in the brain and body.

Patients with depression are at higher risk of cardiovascular disease, and a new study suggests that stress may help explain why. Research from Mass General Brigham suggests that this increased risk ...